GNCA - Genocea Biosciences Inc. (GNCA) CEO William Clark on Q4 2021 Results - Earnings Call Transcript
Genocea Biosciences, Inc. (GNCA) Q4 2021 Earnings Conference Call March 10, 2022, 08:30 ET Company Participants Daniel Ferry - LifeSci Advisors William Clark - President, CEO & Director Diantha Duvall - CFO & Secretary Thomas Davis - Chief Medical Officer Jessica Flechtner - Chief Scientific Officer Conference Call Participants Benjamin Burnett - Stifel, Nicolaus & Company Colleen Kusy - Robert W. Baird & Co. Gil Blum - Needham & Company Joseph Pantginis - H.C. Wainwright & Co. Presentation Operator Good morning, and welcome to the Genocea Fourth Quarter 2021 Conference Call. [Operator Instructions]. Please be advised that this call is being recorded at the company's request. At this time, I'd like to turn the call over to Daniel Ferry of LifeSci Advisors. Please proceed. Daniel Ferry Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlines the topics we plan to discuss today. This
For further details see:
Genocea Biosciences, Inc. (GNCA) CEO William Clark on Q4 2021 Results - Earnings Call Transcript